Madopar®

FH

F. Hoffmann-La Roche Ltd

Manufacturer · Finished Dosage FormsSwitzerland

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Tablets / Immediate-Release Tablets

Trade Type

Sell

Product Name

Madopar®

Details

Benserazide (in the form of Benserazide hydrochloride) 50 mg, Levodopa 200 mg

Substance

Benserazide • Levodopa

Manufacturer(s)

Delpharm Milano S.r.l - Italy

Registered Market

Viet Nam

Specifications

Dosage Form: Tablet
Packaging: Box 1 vial 30 tablet
Strength: Benserazide (dưới dạng Benserazide hydrochloride) 50mg, Levodopa 200mg
Standards: In-house standard
Shelf Life: 48 month

Documents

Drug Marketing Authorization Number

Document No.: 800110349100

Issue Date: Dec 25, 2024

Expiry Date: Dec 25, 2029

Note: 864/QĐ-QLD | 123,1

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product